Back
Inhibrx 10K Form
Sell
49
INBX
Inhibrx
Last Price:
34.96
Seasonality Move:
-13.85%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INBX News And Ratings
See the #1 stock for the next 7 days that we like better than INBX
INBX Financial Statistics
Sales & Book Value
Annual Sales: | $1.8M |
---|---|
Cash Flow: | $-60.26M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.92 |
Price / Book: | 38.13 |
Profitability
EPS (TTM): | -5.12000 |
---|---|
Net Income (TTM): | $-241.36M |
Gross Margin: | -- |
Return on Equity: | -544.89% |
Return on Assets: | -83.9% |
Inhibrx Earnings Forecast
Key Inhibrx Financial Ratios
- The Research & Development expenses have been 10,646.67% of Revenue.
- The Interest Expense is -13.19% of Operating Income.
- The Net Earning history of INBX is -13,408.94% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 1 years.
Inhibrx Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Healthcare |
Current Symbol: | INBX |
Website: | inhibrx.com |
Debt
Debt-to-Equity Ratio: | 4.76 |
---|---|
Current Ratio: | 5.25 |
Quick Ratio: | 4.95 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |